Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Journal of Neurology|October 27, 2004
Plasma homocysteine, MTHFR C677T, CBS 844ins68bp, and MTHFD1 G1958A polymorphisms in spontaneous cervical artery dissectionsCarsten Konrad, Georg A Müller, Claus Langer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Prognostic role of E2F1 and members of the CDKN2A network in gastrointestinal stromal tumorsFlorian Haller, Bastian Gunawan, Anja von Heydebreck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2005
Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapyB Michael Ghadimi, Marian Grade, Michael J Difilippantonio, et al.
Annals of Neurology|December 25, 2009
Role of endogenous testosterone concentration in pediatric strokeSandra Normann, Gabrielle de Veber, Manfred Fobker, et al.
JCO Precision Oncology|February 1, 2023
Genomic Complexity as a Biomarker to De-Escalate Adjuvant Imatinib Treatment in High-Risk Gastrointestinal Stromal TumorKjetil Boye, Ludmila Gorunova, Bastian Gunawan, et al.
Diabetes|September 28, 2002
Polyunsaturated fatty acids and acetoacetate downregulate the expression of the ATP-binding cassette transporter A1Yoshinari Uehara, Thomas Engel, Zhengchen Li, et al.
International Journal of Colorectal Disease|August 6, 2017
The utilization of multidisciplinary tumor boards (MDT) in clinical routine: results of a health care research study focusing on patients with metastasized colorectal cancerMarkus Lowes, Mathias Kleiss, Rainer Lueck, et al.
The Journal of Pathology|April 20, 2004
Site-independent prognostic value of chromosome 9q loss in primary gastrointestinal stromal tumoursBastian Gunawan, Hans-Jürgen Schulten, Anja von Heydebreck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Phase II trial of carcinoembryonic antigen radioimmunotherapy with 131I-labetuzumab after salvage resection of colorectal metastases in the liver: five-year safety and efficacy resultsTorsten Liersch, Johannes Meller, Bettina Kulle, et al.
Pageof 4